APA

Recchia F., Lalli A., Lombardo M., De Filippis S., Saggio G., Fabbri F., Rosselli M., Capomolla E. & Rea S. (20010920). Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. : Cancer.

Chicago

Recchia F, Lalli A, Lombardo M, De Filippis S, Saggio G, Fabbri F, Rosselli M, Capomolla E and Rea S. 20010920. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. : Cancer.

Harvard

Recchia F., Lalli A., Lombardo M., De Filippis S., Saggio G., Fabbri F., Rosselli M., Capomolla E. and Rea S. (20010920). Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. : Cancer.

MLA

Recchia F, Lalli A, Lombardo M, De Filippis S, Saggio G, Fabbri F, Rosselli M, Capomolla E and Rea S. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study. : Cancer. 20010920.